SUMO1 and central nervous system cancer: In the context of glioma, Zhu et al. [11] revealed a distinctive relationship between SUMOylation and glioma, characterized by heightened prolyl cis/trans isomerase NIMA-interacting 1 (Pin1) expression leading to hyperSUMOylation of SUMO1-modified proteins in glioma stem cells.